Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Sponsor: Centessa Pharmaceuticals (UK) Limited
Summary
This study is a long-term extension (LTE) of the parent Study ORX750 0201, and will provide long-term open-label safety, tolerability, and efficacy of ORX750 in participants with narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH).
Official title: A Phase 2, Long-term Extension Study of the Safety and Efficacy of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia Who Completed a Sponsored ORX750 Clinical Trial
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2025-08-12
Completion Date
2026-04-30
Last Updated
2026-03-19
Healthy Volunteers
No
Interventions
ORX750
Oral ORX750
ORX750
Oral ORX750
ORX750
Oral ORX750
Locations (14)
Auburn, alabama
Auburn, Alabama, United States
Santa Ana, California
Santa Ana, California, United States
Miami, Florida
Miami, Florida, United States
Atlanta, Georgia
Atlanta, Georgia, United States
Atlanta, Georgia
Atlanta, Georgia, United States
Sterling Heights, Michigan
Sterling Heights, Michigan, United States
Hendersen, Navada
Henderson, Nevada, United States
Denver, North Carolina
Denver, North Carolina, United States
Huntersville, North Carolina
Huntersville, North Carolina, United States
Cincinnati, Ohio
Cincinnati, Ohio, United States
Willow Grove, Pennsylvania
Willow Grove, Pennsylvania, United States
North Charleston, South Carolina
North Charleston, South Carolina, United States
Austin, Texas
Austin, Texas, United States
El Paso, Texas
El Paso, Texas, United States